Global Biomarker Testing Services 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR042513433

Publication Date:

April 24, 2025

Pages:

106

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Biomarker Testing Services market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Biomarker testing services听help evaluate molecular pathways leading to diseases, and biomarkers assay development helps in target identification and mechanism of action (MOA). In preclinical development, biomarker assay testing enables dose selection, MOA, and safety assessment.

This report is a detailed and comprehensive analysis for global Biomarker Testing Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biomarker Testing Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Biomarker Testing Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Biomarker Testing Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Biomarker Testing Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biomarker Testing Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biomarker Testing Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioAgilytix Labs, Eurofins Scientific, SGS SA, Charles River Laboratories, Labcorp Drug Development, Thermo Fisher Scientific Inc.(PPD, Inc.), ICON Plc, IQVIA, Syneos Health, Intertek Group Plc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Biomarker Testing Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Biomarker Assay Development
Flow Cytometry
Others
麻豆原创 segment by Application
Pharmaceutical and biotechnology companies
Research Institutes
CRO
麻豆原创 segment by players, this report covers
BioAgilytix Labs
Eurofins Scientific
SGS SA
Charles River Laboratories
Labcorp Drug Development
Thermo Fisher Scientific Inc.(PPD, Inc.)
ICON Plc
IQVIA
Syneos Health
Intertek Group Plc
ACM Global Laboratories
Ardena
Cerba Research
Svar Life Science
ABL, Inc.
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biomarker Testing Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biomarker Testing Services, with revenue, gross margin, and global market share of Biomarker Testing Services from 2020 to 2025.
Chapter 3, the Biomarker Testing Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Biomarker Testing Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biomarker Testing Services.
Chapter 13, to describe Biomarker Testing Services research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Biomarker Testing Services by Type
1.3.1 Overview: Global Biomarker Testing Services 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Biomarker Testing Services Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Biomarker Assay Development
1.3.4 Flow Cytometry
1.3.5 Others
1.4 Global Biomarker Testing Services 麻豆原创 by Application
1.4.1 Overview: Global Biomarker Testing Services 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Pharmaceutical and biotechnology companies
1.4.3 Research Institutes
1.4.4 CRO
1.5 Global Biomarker Testing Services 麻豆原创 Size & Forecast
1.6 Global Biomarker Testing Services 麻豆原创 Size and Forecast by Region
1.6.1 Global Biomarker Testing Services 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Biomarker Testing Services 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Biomarker Testing Services 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Biomarker Testing Services 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Biomarker Testing Services 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Biomarker Testing Services 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Biomarker Testing Services 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 BioAgilytix Labs
2.1.1 BioAgilytix Labs Details
2.1.2 BioAgilytix Labs Major Business
2.1.3 BioAgilytix Labs Biomarker Testing Services Product and Solutions
2.1.4 BioAgilytix Labs Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 BioAgilytix Labs Recent Developments and Future Plans
2.2 Eurofins Scientific
2.2.1 Eurofins Scientific Details
2.2.2 Eurofins Scientific Major Business
2.2.3 Eurofins Scientific Biomarker Testing Services Product and Solutions
2.2.4 Eurofins Scientific Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Eurofins Scientific Recent Developments and Future Plans
2.3 SGS SA
2.3.1 SGS SA Details
2.3.2 SGS SA Major Business
2.3.3 SGS SA Biomarker Testing Services Product and Solutions
2.3.4 SGS SA Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 SGS SA Recent Developments and Future Plans
2.4 Charles River Laboratories
2.4.1 Charles River Laboratories Details
2.4.2 Charles River Laboratories Major Business
2.4.3 Charles River Laboratories Biomarker Testing Services Product and Solutions
2.4.4 Charles River Laboratories Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Charles River Laboratories Recent Developments and Future Plans
2.5 Labcorp Drug Development
2.5.1 Labcorp Drug Development Details
2.5.2 Labcorp Drug Development Major Business
2.5.3 Labcorp Drug Development Biomarker Testing Services Product and Solutions
2.5.4 Labcorp Drug Development Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Labcorp Drug Development Recent Developments and Future Plans
2.6 Thermo Fisher Scientific Inc.(PPD, Inc.)
2.6.1 Thermo Fisher Scientific Inc.(PPD, Inc.) Details
2.6.2 Thermo Fisher Scientific Inc.(PPD, Inc.) Major Business
2.6.3 Thermo Fisher Scientific Inc.(PPD, Inc.) Biomarker Testing Services Product and Solutions
2.6.4 Thermo Fisher Scientific Inc.(PPD, Inc.) Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Thermo Fisher Scientific Inc.(PPD, Inc.) Recent Developments and Future Plans
2.7 ICON Plc
2.7.1 ICON Plc Details
2.7.2 ICON Plc Major Business
2.7.3 ICON Plc Biomarker Testing Services Product and Solutions
2.7.4 ICON Plc Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 ICON Plc Recent Developments and Future Plans
2.8 IQVIA
2.8.1 IQVIA Details
2.8.2 IQVIA Major Business
2.8.3 IQVIA Biomarker Testing Services Product and Solutions
2.8.4 IQVIA Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 IQVIA Recent Developments and Future Plans
2.9 Syneos Health
2.9.1 Syneos Health Details
2.9.2 Syneos Health Major Business
2.9.3 Syneos Health Biomarker Testing Services Product and Solutions
2.9.4 Syneos Health Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Syneos Health Recent Developments and Future Plans
2.10 Intertek Group Plc
2.10.1 Intertek Group Plc Details
2.10.2 Intertek Group Plc Major Business
2.10.3 Intertek Group Plc Biomarker Testing Services Product and Solutions
2.10.4 Intertek Group Plc Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Intertek Group Plc Recent Developments and Future Plans
2.11 ACM Global Laboratories
2.11.1 ACM Global Laboratories Details
2.11.2 ACM Global Laboratories Major Business
2.11.3 ACM Global Laboratories Biomarker Testing Services Product and Solutions
2.11.4 ACM Global Laboratories Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 ACM Global Laboratories Recent Developments and Future Plans
2.12 Ardena
2.12.1 Ardena Details
2.12.2 Ardena Major Business
2.12.3 Ardena Biomarker Testing Services Product and Solutions
2.12.4 Ardena Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Ardena Recent Developments and Future Plans
2.13 Cerba Research
2.13.1 Cerba Research Details
2.13.2 Cerba Research Major Business
2.13.3 Cerba Research Biomarker Testing Services Product and Solutions
2.13.4 Cerba Research Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Cerba Research Recent Developments and Future Plans
2.14 Svar Life Science
2.14.1 Svar Life Science Details
2.14.2 Svar Life Science Major Business
2.14.3 Svar Life Science Biomarker Testing Services Product and Solutions
2.14.4 Svar Life Science Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Svar Life Science Recent Developments and Future Plans
2.15 ABL, Inc.
2.15.1 ABL, Inc. Details
2.15.2 ABL, Inc. Major Business
2.15.3 ABL, Inc. Biomarker Testing Services Product and Solutions
2.15.4 ABL, Inc. Biomarker Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 ABL, Inc. Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Biomarker Testing Services Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Biomarker Testing Services by Company Revenue
3.2.2 Top 3 Biomarker Testing Services Players 麻豆原创 Share in 2024
3.2.3 Top 6 Biomarker Testing Services Players 麻豆原创 Share in 2024
3.3 Biomarker Testing Services 麻豆原创: Overall Company Footprint Analysis
3.3.1 Biomarker Testing Services 麻豆原创: Region Footprint
3.3.2 Biomarker Testing Services 麻豆原创: Company Product Type Footprint
3.3.3 Biomarker Testing Services 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Biomarker Testing Services Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Biomarker Testing Services 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Biomarker Testing Services Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Biomarker Testing Services 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Biomarker Testing Services Consumption Value by Type (2020-2031)
6.2 North America Biomarker Testing Services 麻豆原创 Size by Application (2020-2031)
6.3 North America Biomarker Testing Services 麻豆原创 Size by Country
6.3.1 North America Biomarker Testing Services Consumption Value by Country (2020-2031)
6.3.2 United States Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Biomarker Testing Services Consumption Value by Type (2020-2031)
7.2 Europe Biomarker Testing Services Consumption Value by Application (2020-2031)
7.3 Europe Biomarker Testing Services 麻豆原创 Size by Country
7.3.1 Europe Biomarker Testing Services Consumption Value by Country (2020-2031)
7.3.2 Germany Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Testing Services Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Biomarker Testing Services Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Biomarker Testing Services 麻豆原创 Size by Region
8.3.1 Asia-Pacific Biomarker Testing Services Consumption Value by Region (2020-2031)
8.3.2 China Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Biomarker Testing Services Consumption Value by Type (2020-2031)
9.2 South America Biomarker Testing Services Consumption Value by Application (2020-2031)
9.3 South America Biomarker Testing Services 麻豆原创 Size by Country
9.3.1 South America Biomarker Testing Services Consumption Value by Country (2020-2031)
9.3.2 Brazil Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Testing Services Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Biomarker Testing Services Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Biomarker Testing Services 麻豆原创 Size by Country
10.3.1 Middle East & Africa Biomarker Testing Services Consumption Value by Country (2020-2031)
10.3.2 Turkey Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Biomarker Testing Services 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Biomarker Testing Services 麻豆原创 Drivers
11.2 Biomarker Testing Services 麻豆原创 Restraints
11.3 Biomarker Testing Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Biomarker Testing Services Industry Chain
12.2 Biomarker Testing Services Upstream Analysis
12.3 Biomarker Testing Services Midstream Analysis
12.4 Biomarker Testing Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

BioAgilytix Labs
Eurofins Scientific
SGS SA
Charles River Laboratories
Labcorp Drug Development
Thermo Fisher Scientific Inc.(PPD, Inc.)
ICON Plc
IQVIA
Syneos Health
Intertek Group Plc
ACM Global Laboratories
Ardena
Cerba Research
Svar Life Science
ABL, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.